Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IDC | PRODUCT CODE: 1370168

Cover Image

PUBLISHER: IDC | PRODUCT CODE: 1370168

IDC FutureScape: Worldwide Life Sciences 2024 Predictions

PUBLISHED:
PAGES: 20 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 7500

Add to Cart

This IDC study discusses the top 10 predictions for the life sciences industry for 2024."'Reinvent' is very much the new tagline for the life sciences industry. The 2024 worldwide life sciences industry predictions focus on how the life sciences industry is reinventing itself by embedding 'as a service' and 'by design' strategies in its business models, leveraging GenAI to reimagine business processes, and weaving in intelligence and 'hyper-personalization' every step of the way," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.

Product Code: US51290923

IDC FutureScape Figure

Executive Summary

IDC FutureScape Predictions

  • Summary of External Drivers
  • Predictions: Impact on Technology Buyers
    • Prediction 1: By 2024, 70% of Life Sciences Organizations Will Prioritize Security-by-Design, Privacy-by-Design, and Zero Trust Initiatives to Enhance Cyber-Resilience and Build Trust, Fueled by Evolving Regulations
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 2: By 2025, Transformative Patient Experiences Will Be Led by 30% of Life Sciences Firms That Used GenAI to Optimize Trial Design, Hyper-Personalize Content, and Orchestrate Empathetic Interactions
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 3: By 2026, 65% of Life Sciences Companies Will Modernize Digital Infrastructure, Adopting Unified Control Planes to Optimize and Scale Intelligence-Driven Innovation and to Ensure Regulatory Compliance
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 4: Pushed by Data-Driven Market Models and Patient Care Needs, 40% of Life Sciences Companies Will Adopt Integrated Solutions Combining Connected Medical Devices and Digital Health Platforms by 2026
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 5: Fueled by Connected Health Devices and AI-Based Analysis Tools, the Market for Digital Biomarkers Will Double by the End of 2026, Lowering Healthcare Costs While Aiding in R&D and Outcome Measurements
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 6: By 2026, the Adoption of GenAI-Based Drug Design, the Intelligent Supply Chain for Cell and Gene Therapies, and Digital Therapeutics Will Scale the Growth of Precision Therapies by 60%
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 7: Despite the Decreasing Field Sales Head Count, GenAI Enhancements in Commercial Life Sciences Software Will Lead the Industry to a 40% Rise in Personalized Engagements with Healthcare Providers by 2027
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 8: Evolving Home Care Initiatives and Patient Expectations Will Triple the Use of Intelligent Device-Based Drug Delivery Systems by 2027, Followed by Vectorized Antibodies and Gene Delivery Nanocarriers
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 9: By 2027, One-Fourth of the Life Sciences Industry Will Supplement But Not Replace Animal Testing with Computer Simulations, Organoids, and Organ on a Chip, Prioritizing Neurological Diseases
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance
    • Prediction 10: Approvals for Clinical Trials Focused on a Brain-Computer Interface Will Double by 2028, Prioritizing Neurorehabilitation While Implementing Strict Guardrails to Ensure Data Privacy and Patient Safety
      • Associated Drivers
      • IT Impact
      • Patient Impact
      • Guidance

Advice for Technology Buyers

External Drivers: Detail

  • AI Everywhere - Generative AI Takes the Spotlight
  • The Drive to Automate - Maximizing Efficiency and New Opportunities
  • Cybersecurity and Risk - Building Resilience Against Multiplying Threats
  • The Digital Business Imperative - Competitiveness and Outcomes
  • Dynamic Work and Skills Requirements - New Work Mode Era
  • Shifting Tech Regulatory Landscape - Navigating Risk and Opportunity

Learn More

  • Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!